Final Analysis Stage 1 update!
We have now reached and exceeded our target for Analysis Stage 1 (AS1) with 384 participants randomised!
Many thanks to all the site staff participating in Octopus, everyone who has been screened and randomised and all those who are signed on to join Octopus as we move into Analysis Stage 2 (AS2)!
Check out the table below to see how we have done now that AS1 has ended:
| Site | Number Screened | Number Randomised |
| UCLH (London) | 133 | 116 |
| University Hospital Southampton (Southampton) | 43 | 34 |
| The Anne Rowling Regenerative Neurology clinic (Edinburgh) | 58 | 48 |
| Royal Hallamshire Hospital (Sheffield) | 26 | 23 |
| Belfast City Hospital (Belfast) | 44 | 37 |
| Leeds General Infirmary (Leeds) | 24 | 21 |
| University of Wales (Cardiff) | 16 | 16 |
| Poole Hospital (Poole) | 16 | 14 |
| University Hospital Coventry and Warwickshire (Coventry) | 27 | 25 |
| Royal Victoria Infirmary (Newcastle) | 14 | 12 |
| Queens Medical Centre (Nottingham) | 18 | 17 |
| Addenbrooke’s Hospital (Cambridge) | 9 | 8 |
| Morriston Hospital (Swansea) | 11 | 11 |
| Southmead Hospital (Bristol) | 2 | 2 |
| Total | 441 | 384 |
We are now moving into AS2, where we will be opening up more sites in both the UK and Australia.
If you are a potential participant, there may a slight delay in getting in for screening, but so long as you sign up via the Registration of Interest Portal you should receive an email confirming you have registered onto OCTOPUS.
If you have any questions to do with AS2 we have new FAQs or if you have other questions that are not covered in the FAQs, you can contact us directly.
